Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups,...

Full description

Bibliographic Details
Main Authors: Verma, Malvika, Chu, Jacqueline N, Salama, John Ashraf Fou, Faiz, Mohammed T., Eweje, Feyisope, Gwynne, Declan A, Lopes, Aaron C, Hess, Kaitlyn, Soares, Vance, Steiger, Christoph Winfried Johannes, McManus, Rebecca S, Koeppen, Ryan P., Hua, Tiffany P, Hayward, Alison M, Collins, Joy E, Tamang, Siddartha M, Ishida, Keiko, Miller, Jonathan B., Katz, Stephanie, Slocum, Alexander H, Sulkowski, Mark S., Thomas, David L., Langer, Robert S, Traverso, Carlo Giovanni
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:English
Published: National Academy of Sciences 2020
Online Access:https://hdl.handle.net/1721.1/127652

Internet

https://hdl.handle.net/1721.1/127652

Similar Items